Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1651 to 1675 of about 5967

Previous 25

Website Changes

11/25/2016

Clinical and Pre-Clinical Data on Mustang Bio’s MB-101 (IL13Ra2-specific CAR T cells) for the Treatment of Glioblastoma (GBM) Presented at the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology

11/25/2016

ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer

11/24/2016

Dr. Reardon on the KEYNOTE-028 Trial of Pembrolizumab for GBM

11/23/2016

Help Us Better Understand Glioblastoma Multiforme (GBM) Patient Experiences

11/21/2016

Society of Neuro-Oncology Annual Meeting Abstract Now Available Online!

11/21/2016

ImmunoCellular Therapeutics (IMUC) Announces Presentation of Updated ICT-107 Phase 2 Data in GBM

11/21/2016

Tocagen Presents Updated Clinical and Preclinical Data at Scientific Meetings

11/18/2016

Long-Term Analysis of All 695 Patients Enrolled in Novocure’s Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results and Demonstrates Superior Two- and Four-Year Survival Rates

11/09/2016

DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA

11/09/2016

Musella Foundation Co-payment Assistance Program is now closed to new patients

11/09/2016

New vaccine for brain cancer brings hope to those fighting the disease

11/08/2016

Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.

11/07/2016

Novocure Announces 38 Presentations on Tumor Treating Fields at 21st Annual Scientific Meeting of the Society of Neuro-Oncology

11/07/2016

United Healthcare Issues Positive Coverage Decision for Optune

10/25/2016

Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.

10/23/2016

The Musella Foundation announced that it has awarded a $25,000 brain tumor research grant to Dr. Robert Prins of UCLA.

10/22/2016

Patient-Tailored Immunotherapy Shows Promise in Treating Brain Cancer

10/20/2016

An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.

10/09/2016

High response rate in phase I/II paediatric brain cancer trial

10/09/2016

Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha

10/09/2016

Darren Daulton Battling Brain Cancer Through Charitable Foundation

10/09/2016

CIK Treatment Extends Progression-free Survival of Glioblastoma Patients by 1.5 Times

10/09/2016

Last chance for NY Islanders Home Opener Fundraiser!

10/06/2016

Veteran With Terminal Brain Cancer Explains Why He’s Against Assisted Suicide

10/05/2016

Tocagen Presents Updated Tumor Response Data for its Cancer-Selective Gene Therapy

Our privacy / cookie policy has changed.
Click HERE to read it!